Jack Nathan Health signs letter of intent

Jack Nathan Medical Corp. (TSXV: “JNH”; OTCQB: “JNHMF”) (the “Pursue”) announces that following recent press releases from the Company reporting that the Company will evaluate certain strategic alternatives (see Company press releases dated August 13, 2024 and August 7, 2024), the Company has entered into a non-binding letter of intent (the “Letter of intent”) for a proposed transaction. The proposed transaction is subject, among other things, to the negotiation and execution of a definitive agreement (the “Final Agreement”) and the completion of satisfactory due diligence by the other party to the Letter of Intent. In connection with the signing of the Letter of Intent, the Company has agreed to a 30-day exclusivity period with the other party and has secured contingent financing to support the Company’s cash flow needs while the parties work toward negotiating and completing the definitive agreement. The Letter of Intent does not create any legally binding obligations to enter into a definitive agreement and there can be no assurance that a definitive agreement will be signed. If a definitive agreement is signed, the Company will announce details of the transaction at that time.

About Jack Nathan Medical Corp.